Haverford Financial Services, Inc. Abb Vie Inc. Transaction History

Haverford Financial Services, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $664,927 - $740,767	-6,320 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$102.3 - $112.62 $501,270 - $551,838	-4,900 Reduced 43.67%	6,320 $684,000
Q4 2020 Feb 04, 2021	BUY	$80.49 - $108.67 $213,700 - $288,518	2,655 Added 31.0%	11,220 $1.2 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $735,819 - $863,608	8,565 New	8,565 $750,000

3,695

1.27B

13M

9.79M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $349B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Haverford Financial Services, Inc., based on Form 13F filings with the SEC.

Stay updated on Haverford Financial Services, Inc. with notifications on news.